(AZAJ) AllianzIM U.S. Large Cap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00888H7035 • Defined Outcome

AZAJ: Large Cap, Stocks, Options, U.S. Equity, Securities, ETF

The AllianzIM U.S. Large Cap Buffer10 Jan ETF (NYSE ARCA: AZAJ) is designed to provide exposure to U.S. large-cap equities with a defined outcome strategy. The fund invests at least 80% of its net assets in financial instruments that replicate the economic characteristics of U.S. large-cap stocks. These instruments include FLEX Options, which are a type of customizable exchange-traded option. FLEX Options allow the fund to target specific outcomes, such as downside protection or upside participation, over a defined period. The funds strategy is implemented through a portfolio of FLEX Options that reference a specific index, which is typically a broad measure of U.S. large-cap equities. As a non-diversified fund, it may concentrate its investments in a limited number of securities, which can increase risk but also allows for targeted exposure to its underlying index.

From a technical perspective, AZAJ has shown a slight decline in momentum over the past 20 days, with its SMA 20 at 36.73 and SMA 50 at 36.48, both above the current price of 36.05. This suggests potential short-term weakness. However, the SMA 200 at 35.11 indicates that the fund has been in an uptrend over the longer term. The ATR of 0.25 reflects low volatility, which is consistent with the funds risk-managed approach. Average volume over the past 20 days is 16,676 shares, indicating moderate liquidity. With an AUM of $155.99 million, the fund has a manageable size that allows for efficient portfolio management.

Over the next three months, AZAJ is expected to trade within a narrow range, with potential resistance at the SMA 50 level of 36.48 and support near the SMA 200 level of 35.11. The low ATR of 0.25 suggests that price movements will remain stable, with minimal volatility. If the broader market experiences a downturn, the funds downside protection features may become more pronounced, potentially limiting losses. Conversely, if the market rallies, the upside may be capped due to the buffer mechanism. Investors should monitor the funds performance relative to its benchmark index and assess whether the defined outcome strategy aligns with their investment objectives.

Additional Sources for AZAJ ETF

AZAJ ETF Overview

Market Cap in USD 153m
Category Defined Outcome
TER 0.74%
IPO / Inception 2020-12-31

AZAJ ETF Ratings

Growth 5y 63.7%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -1.7
Analysts -
Fair Price Momentum 33.20 USD
Fair Price DCF -

AZAJ Dividends

No Dividends Paid

AZAJ Growth Ratios

Growth Correlation 3m 18.1%
Growth Correlation 12m 95.5%
Growth Correlation 5y 76.4%
CAGR 5y 8.13%
CAGR/Max DD 5y 0.50
Sharpe Ratio 12m 0.89
Alpha -0.87
Beta 0.46
Volatility 19.05%
Current Volume 21.7k
Average Volume 20d 14.8k
What is the price of AZAJ stocks?
As of March 15, 2025, the stock is trading at USD 34.71 with a total of 21,665 shares traded.
Over the past week, the price has changed by -3.11%, over one month by -6.31%, over three months by -3.49% and over the past year by +6.61%.
Is AllianzIM U.S. Large Cap a good stock to buy?
Yes. Based on ValueRay Analyses, AllianzIM U.S. Large Cap (NYSE ARCA:AZAJ) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZAJ as of March 2025 is 33.20. This means that AZAJ is currently overvalued and has a potential downside of -4.35%.
Is AZAJ a buy, sell or hold?
AllianzIM U.S. Large Cap has no consensus analysts rating.
What are the forecast for AZAJ stock price target?
According to ValueRays Forecast Model, AZAJ AllianzIM U.S. Large Cap will be worth about 36.6 in March 2026. The stock is currently trading at 34.71. This means that the stock has a potential upside of +5.56%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.6 5.6%